References
- Atun R, Davies JI, Gale EAM, et al. Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol. 2017;5(8):622–667.
- Mapa-Tassou C, Katte JC, Mba Maadjhou C, et al. Economic impact of diabetes in Africa. Curr Diab Rep. 2019;19(2):5.
- WHO. Global report on diabetes. 2016. Available from http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1.
- International Diabetes Feceration. IDF Africa members. 2019. [cited 2020 Jan 27]. Available from: https://idf.org/our-network/regions-members/africa/members/25-south-africa.html.
- IDF. IDF DIABETES ATLAS Africa. 2019. [cited 2020 Jan 27]. Available from: https://diabetesatlas.org/upload/resources/2019/2019_regional_factsheet.pdf.
- Elliot J, Besançon S, Sachs J. Almost 100 years after it was discovered, let’s make access to insulin a reality in Africa! 2016. [cited 2020 Jan 18]. Available from: https://ideas4development.org/en/almost-100-years-after-it-was-discovered-lets-make-access-to-insulin-a-reality-in-africa/.
- Godman B, Basu D, Pillay Y, et al. Review of ongoing activities and challenges to improve the care of patients with Type 2 diabetes across Africa and the implications for the future. Frontiers in Pharmacology; 2020;11(108).
- Pambou Damiens a, Ganga-Zandzou PS, Tsoucka Ibounde E, et al. Type 1 diabetes mellitus in Gabon: a study of epidemiological aspects. Int J Pediatrics Adolesce Med. 2019;6(3):87–91. .
- Hall V, Thomsen RW, Henriksen O, et al. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. a systematic review. BMC Public Health. 2011;11:564.
- Pastakia SD, Pekny CR, Manyara SM, et al. Diabetes in sub-Saharan Africa - from policy to practice to progress: targeting the existing gaps for future care for diabetes. Diabetes Metab Syndr Obes. 2017;10:247–263.
- Uloko AE, Ofoegbu EN, Chinenye S, et al. Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): results of a multicenter study. Indian J Endocrinol Metab. 2012;16(4):558–564. .
- International Diabetes Federation. IDF Atlas ninth edition. 2019. [cited 2020 Jan 20]. Available from: https://diabetesatlas.org/upload/resources/material/20200106_152211_IDFATLAS9e-final-web.pdf.
- Niba LL Determinants of outcome of children with type 1 diabetes in the North West Region of Cameroon. 2016. [cited 2020 Jan 17]. Available from: https://edoc.ub.uni-muenchen.de/20100/7/Niba_Loveline.pdf.
- Reddy Y, Gannie Y, Pillay K. Characteristics of children presenting with newly diagnosed type1 diabetes. SAJCH. 2013;7(2):46–48c.
- Balcha SA, Phillips DIW, Trimble ER. Type 1 diabetes in a resource-poor setting: malnutrition related, malnutrition modified, or just diabetes? Curr Diab Rep. 2018;18(7):47.
- Marshall SL, Edidin D, Arena VC, et al. Prevalence and incidence of clinically recognized cases of Type 1 diabetes in children and adolescents in Rwanda, Africa. Diabetic Med. 2015;32(9):1186–1192. .
- Marshall SL, Edidin DV, Arena VC, et al. Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education. Diabetes Res Clin Pract. 2015;107(1):113–122. .
- Padoa CJ, Rheeder P, Pirie FJ, et al. Identification of a subgroup of black South Africans with type 1 diabetes who are older at diagnosis but have lower levels of glutamic acid decarboxylase and islet antigen 2 autoantibodies. Diabetic Med. 2019. DOI:10.1111/dme.14204
- Patterson CC, Karuranga S, Salpea P, et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107842.
- Bahendeka SK. Diabetes in sub-Saharan Africa: let us not forget type 1. Lancet Diabetes Endocrinol. 2017;5(8):575–577.
- International Diabetes Federation. IDF ninth edition - country summary table. 2019. Available from: https://diabetesatlas.org/en/resources/.
- Jasem D, Majaliwa ES, Ramaiya K, et al. Incidence, prevalence and clinical manifestations at onset of juvenile diabetes in Tanzania. Diabetes Res Clin Pract. 2020;11(108).
- da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, et al. IDF diabetes atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract. 2016;117:48–54.
- Pei F Managing diabetes in Urban Ghana: is it affordable? 2015. [cited 2020 Jan 20]. Available from: https://dukespace.lib.duke.edu/dspace/bitstream/handle/10161/10014/Pei_duke_0066N_12921.pdf?sequence=1&isAllowed=y.
- Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract. 2002;56(3):197–205.
- International Diabetes Federation. IDF Africa members - Ghana. 2017. Available from: https://idf.org/our-network/regions-members/africa/members/11-ghana.html.
- IDF. Middle East and North Africa. 2019. [cited 2020 Jan 17]. Available from: https://idf.org/our-network/regions-members/middle-east-and-north-africa/members/41-morocco.html. Accessed 17 January 2020
- Dinar Y, Belahsen R. Diabetes mellitus in Morocco: situation and challenges of diabetes care. J Sci Res Rep. 2014;3(19):2477–2485.
- Chetoui a, Kaoutar K, Kardoudi a, et al. Epidemiology of diabetes in Morocco: review of data, analysis and perspectives. Int J Sci Eng Res. 2018;9(12):1310–1316.
- Adekanmbi VT, Uthman OA, Erqou S, et al. Epidemiology of prediabetes and diabetes in Namibia, Africa: a multilevel analysis. J Diabetes. 2019;11(2):161–172.
- Ugege O, Ibitoye PK, Jiya NM. Childhood diabetes mellitus in sokoto, north-western Nigeria: a ten year review. Sahel Med J. 2013;16:97–101.
- Adeleke SI, Asani MO, Belonwu RO, et al. Childhood diabetes mellitus in Kano, North West, Nigeria. Niger J Med. 2010;19(2):145–147.
- Ibekwe MU, Ibekwe RC. Pattern of Type 1 diabetes mellitus in Abakaliki, Southeastern, Nigeria. Pediatr Oncall J. 2011;8:59–62.
- Umar UI. Pattern of presentation of Type 1 diabetic patients in Kano, Nigeria. Niger J Basic Clin Sci. 2016;13:85–88.
- John C, Abok II, Yilgwan C. Clinical profile of childhood type 1 diabetes in Jos, Nigeria. AfrJ Diabetes Med. 2013;21(1):11–13.
- de Dieu NJ. Diabetes prevalence in Rwanda at 3% – moH. 2019. [cited 2020 Jan 26]. Available from: https://www.newtimes.co.rw/news/diabetes-prevalence-rwanda-3-moh.
- Mutyambizi C, Booysen F, Stokes a, et al. Lifestyle and socio-economic inequalities in diabetes prevalence in South Africa: a decomposition analysis. PloS One. 2019;14(1):e0211208.
- Ekpebegh CO, Longo-Mbenza B. Clinical, immunologic and insulin secretory characteristics of young black South African patients with diabetes: hospital based single centre study. Diabetes Res Clin Pract. 2013;99(3):380–384.
- Elamin A, Ghalib M, Eltayeb B, et al. High incidence of type 1 diabetes mellitus in Sudanese children, 1991-1995. Ann Saudi Med. 1997;17(4):478–480.
- World Health Organisation. Country profile - Zambia. 2019. [cited 2020 Feb 3]. Available from: https://www.who.int/diabetes/country-profiles/zmb_en.pdf?ua=1.
- Mutowo M, Gowda U, Mangwiro JC, et al. Prevalence of diabetes in Zimbabwe: a systematic review with meta-analysis. Int J Public Health. 2015;60(1):1–11.
- Pirie FJ, Pegoraro R, Motala AA, et al. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens. 2005;66(2):125–130. .
- Piloya-Were T, Sunni M, Ogle GD, et al. Childhood diabetes in Africa. Curr Opin Endocrinol Diabetes Obes. 2016;23(4):306–311.
- Chikani UN, Bisi-Onyemaechi AI, Oguonu T, et al. Childhood diabetes: a myth or reality?- perception of the public from a low-income country: a cross-sectional study. BMC Public Health. 2018;18(1):852.
- Panz VR, Kalk WJ, Zouvanis M, et al. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa. Diabetic Med. 2000;17(7):524–527.
- Fasanmade OA, Dagogo-Jack S. Diabetes care in Nigeria. Ann Glob Health. 2015;81(6):821–829.
- Ogbera AO, Fasanmade O, Ohwovoriole AE, et al. An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds. 2006;5(4):244–249.
- Quaye EA, Amporful EO, Akweongo P, et al. Analysis of the financial cost of diabetes mellitus in Four Cocoa Clinics of Ghana. Value Health Reg Issues. 2015;7:49–53.
- Suleiman IA, Festus JA. Cost of illness among diabetes mellitus patients in Niger Delta, Nigeria. J Pharm Health Serv Res. 2015;6(1):53–60.
- Mutale W, Bosomprah S, Shankalala P, et al. Assessing capacity and readiness to manage NCDs in primary care setting: gaps and opportunities based on adapted WHO PEN tool in Zambia. PloS One. 2018;13(8):e0200994–e. .
- Ministry of Health and Social Services, Primary Health Care Directorate, Namibia. National multisectoral strategic plan for prevention and control of Non-Communicable Diseases (NCDs) in Namibia 2017/18 – 2021/22. 2017. [cited 2020 Jan 15]. Available from: https://www.iccp-portal.org/system/files/plans/NAMIBIA%20NATIONAL%20MULTISECTORAL%20STRATEGIC%20PLAN%20FOR%20PREVENTION%20AND%20CONTROL%20OF%20NCDs.pdf.
- Mukanu MM, Zulu JM, Mweemba C, et al. Responding to non-communicable diseases in Zambia: a policy analysis. Health Res Policy Syst. 2017;15(1):34.
- Federal Ministry of Health, SIDCAIN, World Diabetes Foundation. Diabetes and NCDs in Nigeria - perspectives, challenges & the way forward. 2017. [cited 2020 Jan 18]. Available from: http://sidcain.org/download/ABUJA%20Proceedings%20Reviewed%20Nov%202017.pdf.
- NDOH. National department of health republic of South Africa. Adherence guidelines for HIV, TB and NCDs. Policy and service delivery guidelines to care, adherence to treatment and retention in care. February 2016. [cited 2020 Feb 5]. Available from: https://www.nacosa.org.za/wp-content/uploads/2016/11/Integrated-Adherence-Guidelines-NDOH.pdf
- Kingdom of Eswatini - Ministry of Health. NATIONAL PREVENTION AND CONTROL OF NON COMMUNICABLE DISEASES (NCDs). 2017 Annual Program Report; 2017.
- Igbojiaku OJ, Harbor OC, Ross a. Compliance with diabetes guidelines at a regional hospital in KwaZulu-Natal, South Africa. Afr J Prim Health Care Fam Med. 2013;5(1):447.
- SEMDSA. 2017 Guidelines for the management of Type 2 diabetes mellitus. SEMDSA Type 2 diabetes guidelines expert committee. JEMDSA. 2017;22(1)(Supplement1):S1–S196.
- Awodele O, Osuolale JA. Medication adherence in type 2 diabetes patients: study of patients in alimosho general hospital, Igando, Lagos, Nigeria. Afr Health Sci. 2015;15(2):513–522.
- Botswana national multisectoral strategy for the prevention and control of non-communicable diseases. 2017. [cited 2020 Jan 17]. Available from: https://www.iccp-portal.org/system/files/plans/20171129%20Botswana%20multisec%20NCDs%20strategy%20-%20final.pdf.
- Khogali SS, Ali WA, Mohamed SY, et al. Knowledge, attitude and practice of Sudanese individuals with type 2 diabetes about medication used in treatment of diabetes, hypertension and dyslipidaemia: a matter of debate or matter of concern? J Public Health Emerg. 2018;2:23.
- Shannon GD, Haghparast-Bidgoli H, Chelagat W, et al. Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project. Glob Health Action. 2019;12(1):1605704.
- International Insulin Foundation – Fact Sheet on diabetes in sub-Saharan Africa. [cited 2020 Jan 20]. Available from: http://www.access2insulin.org/uploads/4/9/1/0/4910107/factsheet.pdf.
- Djonou C, Tankeu AT, Dehayem MY, et al. Glycemic control and correlates in a group of sub Saharan type 1 diabetes adolescents. BMC Res Notes. 2019;12(1):50.
- Balde N, Camara a, Sobngwi-Tambekou J, et al. Improving access to HbA1c in sub-Saharan Africa (IA3) cohort: cohort profile. Pan Afr Med J. 2017;27:275.
- Park PH, Pastakia SD. Access to hemoglobin A1c in rural Africa: a difficult reality with severe consequences. J Diabetes Res. 2018;2018:6093595.
- Republic of Zambia. Ministry of Health. Zambia national health strategic plan 2017–2021. Lusaka; 2017. [cited 2020 Jan 20]. Available from: https://www.moh.gov.zm/docs/ZambiaNHSP.pdf
- Tapela NM, Tshisimogo G, Shatera BP, et al. Integrating noncommunicable disease services into primary health care, Botswana. Bull World Health Organ. 2019;97(2):142–153. .
- WHO Africa. The team Type 1 foundation and abbott partner to donate glucose meters and nearly 12 million test strips to help people living with diabetes in Rwanda. 2020. [cited 2020 Jan 20]. Available from: https://www.afro.who.int/news/team-type-1-foundation-and-abbott-partner-donate-glucose-meters-and-nearly-12-million-test. Accessed 20 January 2020
- Kenya Ministry of Health. Transforming health: accelerating attainment of universal health coverage. The KENYA HEALTH SECTOR STRATEGIC AND INVESTMENT PLAN – KHSSP July 2012 –June; 2017. [cited 2020 Jan 18]. Available from: http://e-cavi.com/wp-content/uploads/2014/11/kenya-health-sector-strategic-investiment-plan-2013-to-2017.pdf Accessed 20 January 2020
- Rampamba EM, Meyer JC, Helberg EA, et al. Empowering hypertensive patients in south Africa to improve their disease management: a pharmacist-led intervention. J Res Pharm Pract. 2019;8(4):208–213.
- Atkilt HS, Turago MG, Tegegne BS. Clinical characteristics of diabetic ketoacidosis in children with newly diagnosed Type 1 diabetes in Addis Ababa, Ethiopia: a cross-sectional study. PloS One. 2017;12(1):e0169666–e.
- Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343.
- Azevedo M, Alla S. Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia. Int J Diabetes Dev Countries. 2008;28(4):101–108.
- Onyiriuka AN, Ifebi E. Ketoacidosis at diagnosis of type 1 diabetes in children and adolescents: frequency and clinical characteristics. J Diabetes Metab Disord. 2013;12(1):47.
- Murunga AN, Owira PM. Diabetic ketoacidosis: an overlooked child killer in sub-Saharan Africa? Trop Med Int Health. 2013;18(11):1357–1364.
- Ndebele NFM, Naidoo M. The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal. Afr J Prim Health Care Fam Med. 2018;10(1):e1–e6.
- Majaliwa ES, Mohn a, Chiavaroli V, et al. Management of diabetic ketoacidosis in children and adolescents in sub-Saharan Africa: a review. East Afr Med J. 2010;87(4):167–173.
- Iovane B, Cangelosi AM, Bonaccini I, et al. Diabetic ketoacidosis at the onset of Type 1 diabetes in young children is it time to launch a tailored campaign for DKA prevention in children. Acta Biomed. 2018;89(1):67–71. .
- Van Zyl DG. Diagnosis and treatment of diabetic ketoacidosis. S Afr Family Pract. 2008;50(1):35–39.
- Ngwiri T, Were F, Predieri B, et al. Glycemic Control in Kenyan children and adolescents with Type 1 diabetes mellitus. Int J Endocrinol. 2015;2015:761759.
- Mukama LJ, Moran a, Nyindo M, et al. Improved glycemic control and acute complications among children with type 1 diabetes mellitus in Moshi, Tanzania. Pediatr Diabetes. 2013;14(3):211–216.
- Emral R, Pathan F, Cortés CAY, et al. Self-reported hypoglycemia in insulin-treated patients with diabetes: results from an international survey on 7289 patients from nine countries. Diabetes Res Clin Pract. 2017;134:17–28.
- Kalweit KL, Briers N, Olorunju S. The success of various management techniques used in South African children with type 1 diabetes mellitus. S Afr Med J. 2015;105(5):400–404.
- Fulcher G, Singer J, Castañeda R, et al. The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys. J Med Econ. 2014;17(10):751–761. .
- Muddu M, Mutebi E, Ssinabulya I, et al. Hypertension among newly diagnosed diabetic patients at Mulago national referral hospital in Uganda: a cross sectional study. Cardiovasc J Afr. 2018;29(4):218–224.
- Ahmed SA, Badi S, Tahir H, et al. Knowledge and practice of diabetic foot care in Sudan: a cross sectional survey. Diabetes Metab Syndr. 2019;13(4):2431–2435.
- Wagnew F, Eshetie S, Kibret GD, et al. Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis. BMC Res Notes. 2018;11(1):565. .
- Hapunda G, Abubakar a, van de Vijver F, et al. Living with type 1 diabetes is challenging for Zambian adolescents: qualitative data on stress, coping with stress and quality of care and life. BMC Endocr Disord. 2015;15:20.
- Rwegerera GM, Moshomo T, Gaenamong M, et al. Health-related quality of life and associated factors among patients with diabetes mellitus in Botswana. Alexandria J Med. 2018;54(2):111–118. .
- da Mata AR, Alvares J, Diniz LM, et al. Quality of life of patients with diabetes mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil. Expert Rev Clin Pharmacol. 2016;9(5):739–746. .
- Nieuwesteeg a, Pouwer F, van der Kamp R, et al. Quality of life of children with type 1 diabetes: a systematic review. Curr Diabetes Rev. 2012;8(6):434–443.
- Oluyombo R, Okunola OO, Olanrewaju TO, et al. Challenges of hemodialysis in a new renal care center: call for sustainability and improved outcome. Int J Nephrol Renovasc Dis. 2014;7:347–352.
- Makhele L, Matlala M, Sibanda M, et al. a Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa. Pharmacoecon Open. 2019;3(4):631-41.
- Beran D, Hirsch IB, Yudkin JS. Why Are We Failing to Address the Issue of Access to Insulin? a National and Global Perspective. Diabetes Care. 2018;41(6):1125–1131.
- Mansfield J TYPE 1 DIABETES IN GHANA: a GLOBAL COMMUNITY DISCUSSION. 2018. [cited 2020 Jan 20]. Available from: https://beyondtype1.org/type-1-diabetes-ghana/.
- Pirie FJ, Jairam V, Paruk IM, et al. High frequency of hypoglycaemia in patients with type 1 diabetes mellitus attending a tertiary diabetes clinic in Durban, South Africa. Diabetes Res Clin Pract. 2019;155:107783.
- Beran D, Ewan M, Laing R Access to insulin - Current Challenges & Constraints. October 2015. [cited 2020 Jan 19]. Available from: https://apps.who.int/medicinedocs/documents/s22269en/s22269en.pdf.
- Ewen M, Joosse HJ, Beran D, et al. Insulin prices, availability and affordability in 13 low-income and middle-income countries. BMJ Glob Health. 2019;4(3):e001410.
- Beran D, Ewen M, Laing R. Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol. 2016;4(3):275–285.
- Beran D, Laing RO, Kaplan W, et al. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices. Diabetic Med. 2019;36(6):726–733. .
- Tiruneh GG, Abebe N, Dessie G. Self-reported hypoglycemia in adult diabetic patients in East Gojjam, Northwest Ethiopia: institution based cross-sectional study. BMC Endocr Disord. 2019;19(1):17.
- Kahsay H, Fantahun B, Nedi T, et al. Evaluation of Hypoglycemia and Associated Factors among Patients with Type 1 Diabetes on Follow-Up Care at St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. J Diabetes Res. 2019;2019:9037374.
- Kratzer J. Structural barriers to coping with type 1 diabetes mellitus in Ghana: experiences of diabetic youth and their families. Ghana Med J. 2012;46(2 Suppl):39–45.
- TiInternational. Ghana. [cited 2020 Jan 20]. Available from: https://www.t1international.com/Ghana/.
- World Health Organisation (WHO). Global action Plan for the prevention and control of noncommunicable diseases. 2013. [cited 2020 Jan 18]. Available from: https://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf;jsessionid=7E6647ED415CFBF876A7CC201127FB76?sequence=1.
- Kapwata T, Manda S. Geographic assessment of access to health care in patients with cardiovascular disease in South Africa. BMC Health Serv Res. 2018;18(1):197.
- Sandoz - a Novartis Division. Kenya is first country to launch ‘Novartis Access’, expanding affordable treatment options against chronic diseases. 2015. [cited 2020 Jan 18]. Available from: https://www.sandoz.com/news/media-releases/kenya-first-country-launch-novartis-access-expanding-affordable-treatment.
- Kabeza CB, Harst L, Schwarz PEH, et al. Assessment of Rwandan diabetic patients’ needs and expectations to develop their first diabetes self-management smartphone application (Kir’App). Ther Adv Endocrinol Metab. 2019;10:2042018819845318.
- Novo Nordisk. NOVO NORDISK EXPANDS PROGRAMME TO REACH 20,000 CHILDREN WITH DIABETES IN DEVELOPING COUNTRIES. 2016. [cited 2020 Jan 19]. Available from: http://www.multivu.com/players/uk/7962351-novo-nordisk-programme-children-diabetes/.
- Roche. Changing diabetes care for children in Africa. 2019. [cited 2020 Jan 22]. Available from: https://www.roche.com/sustainability/access-to-healthcare/ath_diabetes.htm.
- Pillay DK, Ross AJ, Campbell L. A review of hypoglycaemia in a South African family practice setting. Afr J Prim Health Care Fam Med. 2016;8(1):e1–e6.
- Kaplan H, Amodb a, van Zyk FH, et al. Incidence of hypoglycaemia in the South African population with diabetes: results from the IDMPS Wave 7 study. J Endocrinol Metabolism Diabetes South Afr. 2019;24(2):58–64.
- WHO. World health organization model list of essential medicines 2019. [cited 2020 Jan 20]. Available from: https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=21stList 201.
- Ogle GD, Kim H, Middlehurst AC, et al. Financial costs for families of children with Type 1 diabetes in lower-income countries. Diabetic Med. 2016;33(6):820–826.
- Ogle GD, Middlehurst AC, Silink M. The IDF life for a child program index of diabetes care for children and youth. Pediatr Diabetes. 2016;17(5):374–384.
- Silver B, Ramaiya K, Andrew SB, et al. EADSG guidelines: insulin therapy in diabetes. Diabetes Therapy. 2018;9(2):449–492. .
- Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293–301. .
- Sherif S, Sumpio BE. Economic development and diabetes prevalence in MENA countries: Egypt and Saudi Arabia comparison. World J Diabetes. 2015;6(2):304–311.
- Pastakia SD, Nuche-Berenguer B, Pekny CR, et al. Retrospective assessment of the quality of diabetes care in a rural diabetes clinic in Western Kenya. BMC Endocr Disord. 2018;18(1):97. .
- Matheka DM, Kilonzo JM, Munguti CM, et al. Pattern, knowledge and practices of HbA1C testing among diabetic patients in a Kenyan tertiary referral hospital. Global Health. 2013;9:55.
- Mbui JM, Oluka MN, Guantai EM, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1263–1271. .
- Nashilongo MM, Singu B, Kalemeera F, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5–6):565–578. .
- Fadare J, Olamoyegun M, Gbadegesin BA. Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi Med J. 2015;27(2):65–70.
- Mutyambizi C, Pavlova M, Chola L, et al. Cost of diabetes mellitus in Africa: a systematic review of existing literature. Global Health. 2018;14(1):3.
- Ogbera AO, Kuku SF. Insulin use, prescription patterns, regimens and costs.-a narrative from a developing country. Diabetol Metab Syndr. 2012;4(1):50.
- Onyiriuka N, Ezomo OO, Onyiriuka RC. Cost of treating insulin-requiring diabetes in children and adolescents. J Inst Med. 2012;34(1):2–8.
- Yamey G, Fewer S, Beyeler N. Achieving a “grand convergence” in global health by 2035: Rwanda shows the way comment on “improving the world’s health through the post-2015 development agenda: perspectives from Rwanda”. Int J Health Policy Manag. 2015;4(11):789–791.
- Rwanda Diabetes Association. 2019. [cited 2020 Feb 8]. Available from: https://rwandadiabetes.com/.
- The Global Fund. Global fund grants in the republic of Sudan - GF-OIG-19-010. Geneva, Switzerland. 2019. [cited 2020 Feb 3]. Available from: https://www.theglobalfund.org/media/8433/oig_gf-oig-19-010_report_en.pdf?u=637066540330000000.
- Mohamed Ali GK. 3,121 days in the driving seat of the national medical supplies fund: what lessons to be shared? Book manuscript under proofreading for publication.
- Elrayah H, Eltom M, Bedri a, et al. Economic burden on families of childhood type 1 diabetes in urban Sudan. Diabetes Res Clin Pract. 2005;70(2):159–165.
- Eliadarous H. Exploring the impact of diabetes in Sudan: out-of-pocket expenditure and social consequences of diabetes on patients and their families. Stockholm, Sweden; 2017. [cited 2020 Jan 17]. Available from: https://openarchive.ki.se/xmlui/bitstream/handle/10616/45956/Thesis_Hind_Eliadarous.pdf?sequence=1&isAllowed=y
- Peck R, Mghamba J, Vanobberghen F, et al. Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey. Lancet Glob Health. 2014;2(5):e285–e92. .
- Kalungia CA, Mwale M, Sondashi IS, et al. Availability of essential antihypertensive and antidiabetic medicines in public health facilities in Lusaka District, Zambia. Med J Zambia. 2017;44(3):140–148.
- Kaiser AH, Hehman L, Forsberg BC, et al. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia. PloS One. 2019;14(12):e0226169–e.
- Moucheraud C, Lenz C, Latkovic M, et al. The costs of diabetes treatment in low– and middle–income countries: a systematic review. BMJ global health.. 2019;4(1):e001258.
- Jaam M, Ibrahim MIM, Kheir N, et al. Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: a systematic mixed studies review. Diabetes Res Clin Pract. 2017;129:1–15.
- Majaliwa ES, Elusiyan BE, Adesiyun OO, et al. Type 1 diabetes mellitus in the African population: epidemiology and management challenges. Acta Biomed. 2008;79(3):255–259.
- Manne-Goehler J, Geldsetzer P, Agoudavi K, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLoS Med. 2019;16(3):e1002751. .
- Owolabi MO, Yaria JO, Daivadanam M, et al. Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review. Diabetes Care. 2018;41(5):1097–1105. .
- Godman B, Haque M, McKimm J, et al. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Curr Med Res Opin. 2020;36(2):301–327. .
- Godman B, Wettermark B, van Woerkom M, et al. Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Front Pharmacol. 2014;5:106.
- Godman B, Malmstrom RE, Diogene E, et al. Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs. Front Pharmacol. 2014;5:109.
- Godman B, Malmstrom RE, Diogene E, et al. Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? Expert Rev Clin Pharmacol. 2015;8(1):77–94. .
- Godman B, Bucsics a, Vella Bonanno P, et al. Barriers for access to new medicines: searching for the balance between rising costs and limited budgets. Front Public Health. 2018;6:328.
- Ermisch M, Bucsics a, Vella Bonanno P, et al. Payers‘ views of the changes arising through the possible adoption of adaptive pathways. Front Pharmacol. 2016;7:305.
- Godman B, Grobler C, Van-De-Lisle M, et al. Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert Opin Pharmacother. 2019;20(18):2237–2255. .
- Moorkens E, Vulto AG, Huys I, et al. Policies for biosimilar uptake in Europe: an overview. PloS One. 2017;12(12):e0190147.
- World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. [cited 2020 Jan 22]. Available from: https://apps.who.int/iris/bitstream/handle/10665/43588/9241594934_eng.pdf;jsessionid=75A0C3B74F6572D012AB00D9F8A23D4E?sequence=1.
- WHO. Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus. 2018. [cited 2020 Jan 18]. Available from: https://apps.who.int/iris/bitstream/handle/10665/272433/9789241550284-eng.pdf?ua=1.
- Beran D, Ewen M, Lipska K, et al. Availability and affordability of essential medicines: implications for global diabetes treatment. Curr Diab Rep. 2018;18(8):48.
- Ghana National Health Insurance Medicine list 2018. Avaiable from: http://www.nhis.gov.gh/files/2018%20NHIS%20ML.pdf.
- Government of the Kingdom of Swaziland Ministry of Health, the US President’s Emergency Plan for AIDS Relief, USAID, and Strengthening Pharmaceutical Systems (SPS) Program. Standard treatment guidelines and essential medicines list of common medical conditions in the kingdom of Swaziland. 2012. [cited 2020 Jan 20]. Available from: https://apps.who.int/medicinedocs/documents/s22119en/s22119en.pdf.
- Kalk WJ, Raal J, Joffe BI. The prevalence and incidence of and risk factors for, micro-albuminuria among urban Africans with type 1 diabetes in South Africa: an inter-ethnic study. Int J Diabetes Mellitus. 2010;2:148–153.
- Diabetes South Africa. The Tshwane insulin project. 2018. [cited 2020 Jan 18]. Available from: https://www.diabetessa.org.za/the-tshwane-insulin-project/.
- Ntuli C Tuks sets up diabetes treatment programme. 2019. [cited 2020 Feb 9]. Available from: https://www.iol.co.za/pretoria-news/tuks-sets-up-diabetes-treatment-programme-37175398.
- Federal Ministry of Health, Sudan. National essential medicines list, 2014. [cited 2020 Jan 20]. Available from: https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/sudan_national_essential_medicines_list_.pdf.
- Jonker D, Deacon E, van Rensburg E, et al. Illness perception of adolescents with well-controlled type 1 diabetes mellitus. Health Psychol Open. 2018;5(2):2055102918799968.
- Roth GA, Johnson C, Abajobir a, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. .
- Joseph P, Leong D, McKee M, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677–694. .
- Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in. 188 countries: an analysis from the global burden of disease study 2016. Lancet. 2017;390(10100):1423–1459. .
- United Nations. Sustainable development goal 3 - ensure healthy lives and promote well-being for all at all ages. 2019. [cited 2020 Feb 3]. Available from: https://sustainabledevelopment.un.org/sdg3.
- Morton S, Pencheon D, Squires N. Sustainable Development Goals (SDGs), and their implementation: a national global framework for health, development and equity needs a systems approach at every level. Br Med Bull. 2017;124(1):81–90.
- Caires de Souza AL, de Assis Acurcio F, Guerra AA Junior, et al. Insulin glargine in a Brazilian state: should the government disinvest? An assessment based on a systematic review. Appl Health Econ Health Policy. 2014;12(1):19–32.
- de Souza AL, Acurcio Fde a, Guerra Junior AA, et al. Authors’ reply to Dr. Malerbi: “Insulin glargine in a Brazilian state: should the government disinvest?”. Appl Health Econ Health Policy. 2014;12(5):561–563.
- Almeida P, Silva TBC, de Assis Acurcio F, et al. Quality of life of patients with Type 1 diabetes mellitus using insulin analog glargine compared with NPH insulin: a systematic review and policy implications. Patient. 2018;11(4):377–389. .
- Marra LP, Araujo VE, Silva TB, et al. Clinical effectiveness and safety of analog glargine in Type 1 diabetes: a systematic review and meta-analysis. Diabetes Therapy. 2016;7(2):241–258. .
- Institut für qualität und Wirtschaftlichkeit im Gesundheitswesen [Institute of quality and efficiency in health care]: long-acting insulin analogues in the treatment of diabetes mellitus type 1. 2010. Available from: http://www.iqwig.de/download/A05-01_Executive-Summary_Long-acting_insulin_analogues_in_diabetes_mellitus_type_1.pdf
- Holden SE, Poole CD, Morgan CL, et al. Evaluation of the incremental cost to the national health service of prescribing analogue insulin. BMJ Open. 2011;1(2):e000258.
- Horvath K, Jeitler K, Berghold a, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;2007(2):Cd005613.
- Singh SR, Ahmad F, Lal a, et al. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ. 2009;180(4):385–397.
- Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. a meta-analysis. Diabetes Obes Metab. 2009;11(4):372–378.
- NICE. Type 1 diabetes in adults: diagnosis and management NICE guideline [NG17]. 2016. Available from: https://www.nice.org.uk/guidance/ng17.
- Moodie P. More from PHARMAC on long-acting insulin analogues: insulin glargine now funded. N Z Med J. 2006;119(1236):U2040–U.
- Meyer JC, Schellack N, Stokes J, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; A preliminary study. Front Pharmacol. 2017;8:751.